Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Medical Center
- Study ID
- NCT07137949
- Status
- Recruiting
Conditions
- Delirium
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Music therapy — BEHAVIORALLive music therapy (MT) sessions will occur 3 times/week, up to 5 sessions. Sessions will be responsive to patient preferences, culture, and identity using information gained from medical record review, intake assessment, and in the moment therapeutic assessments.
Study Details
In this pilot study a new kind of music therapy will be created and tested to help prevent confusion, called delirium, that can happen in the hospital. This can affect people with brain diseases like Alzheimer's disease and Parkinson's disease. Each of the anticipated 30 participants will have up to five music therapy sessions. The sessions will be made just for them and may include live music, playing instruments, or listening to recorded music. Surveys will be used to learn how easy the therapy is to do in the hospital and what people think about how helpful the sessions may be for future patients.
Key Dates
- Start date
- Mar 11, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Music therapyParticipants will undergo one-on-one music therapy (MT) sessions of approximately 30 minutes duration conducted by a board-certified music therapist. Sessions will be customized to address patient needs but will consistently adhere to the four principal MT methods of re-creation, composition, improvisation, and therapeutic listening experiences.
Primary Outcome Measure
Delirium scores [ Time Frame: every 24 hours until discharge (on average 7 days) ]
Central Contacts
- Kara M Smith, MD MSCI FAAN617-638-5351
- Amber Payne, MS
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Medical Center | Boston | Massachusetts | 02118 | Kara M Smith, MD MSCI FAAN |
Find similar trials in Boston, MA
By research site
Related Studies
- Researching Efficient Approaches to Delirium Identification-Sustaining Effective TranslationRecruiting · Penn State University · Boston, Massachusetts
- CTSN Embolic Protection TrialRecruiting · Icahn School of Medicine at Mount Sinai · North Little Rock, Arkansas
- Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)PHASE3 · Recruiting · Massachusetts General Hospital · Los Angeles, California
- Interventions for Postoperative Delirium: Biomarker-3Recruiting · University of Wisconsin, Madison · Madison, Wisconsin